We have become aware through customer complaints that the measured PlGF analyte concentrations in part of the patient samples (approximately 15%) may be decreased ≥ 50%. The decreased PlGF concentration results may cause raise in the amount of high risk/false positive pre-eclampsia and Down's syndrome screening results. Recall Start Date: May 29, 2024
RecallTracker